Provided by Tiger Fintech (Singapore) Pte. Ltd.

Super League Gaming Inc.

0.3680
+0.02176.27%
Post-market: 0.3662-0.0018-0.49%19:34 EDT
Volume:152.29K
Turnover:54.66K
Market Cap:6.11M
PE:-0.08
High:0.3688
Open:0.3599
Low:0.3463
Close:0.3463
Loading ...

Adicet Bio (ACET): Among the Penny Stocks With Huge Upside Potential According to Analysts

Insider Monkey
·
Yesterday

Super League Enterprise Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
21 Mar

Press Release: Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Dow Jones
·
20 Mar

Alumis Reports Year End 2024 Financial Results and Highlights Recent Achievements

GlobeNewswire
·
20 Mar

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

GlobeNewswire
·
19 Mar

Super League Enterprise, Inc. (NASDAQ:SLE) Not Doing Enough For Some Investors As Its Shares Slump 33%

Simply Wall St.
·
12 Mar

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights

GlobeNewswire
·
11 Mar

EXCLUSIVE: AVID And Super League Bring Learning To Roblox, Helping Teens Build Real-World Skills Through Gaming

Benzinga
·
11 Mar

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress

Business Wire
·
07 Mar

Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

GlobeNewswire
·
06 Mar

Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris

GlobeNewswire
·
28 Feb

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)

Business Wire
·
27 Feb

Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
27 Feb

On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth

PR Newswire
·
27 Feb

This Super League Enterprise Insider Increased Their Holding By 46% Last Year

Simply Wall St.
·
20 Feb

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

GlobeNewswire
·
13 Feb